These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 11108739)

  • 1. LDL receptor deficiency unmasks altered VLDL triglyceride metabolism in VLDL receptor transgenic and knockout mice.
    Tacken PJ; Teusink B; Jong MC; Harats D; Havekes LM; van Dijk KW; Hofker MH
    J Lipid Res; 2000 Dec; 41(12):2055-62. PubMed ID: 11108739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In the absence of the low density lipoprotein receptor, human apolipoprotein C1 overexpression in transgenic mice inhibits the hepatic uptake of very low density lipoproteins via a receptor-associated protein-sensitive pathway.
    Jong MC; Dahlmans VE; van Gorp PJ; van Dijk KW; Breuer ML; Hofker MH; Havekes LM
    J Clin Invest; 1996 Nov; 98(10):2259-67. PubMed ID: 8941642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversal of hyperlipidaemia in apolipoprotein C1 transgenic mice by adenovirus-mediated gene delivery of the low-density-lipoprotein receptor, but not by the very-low-density-lipoprotein receptor.
    Jong MC; van Dijk KW; Dahlmans VE; Van der Boom H; Kobayashi K; Oka K; Siest G; Chan L; Hofker MH; Havekes LM
    Biochem J; 1999 Mar; 338 ( Pt 2)(Pt 2):281-7. PubMed ID: 10024503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Triglyceride-rich lipoprotein metabolism in unique VLDL receptor, LDL receptor, and LRP triple-deficient mice.
    Espirito Santo SM; Rensen PC; Goudriaan JR; Bensadoun A; Bovenschen N; Voshol PJ; Havekes LM; van Vlijmen BJ
    J Lipid Res; 2005 Jun; 46(6):1097-102. PubMed ID: 15772433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Very low density lipoprotein (VLDL) receptor-deficient mice have reduced lipoprotein lipase activity. Possible causes of hypertriglyceridemia and reduced body mass with VLDL receptor deficiency.
    Yagyu H; Lutz EP; Kako Y; Marks S; Hu Y; Choi SY; Bensadoun A; Goldberg IJ
    J Biol Chem; 2002 Mar; 277(12):10037-43. PubMed ID: 11790777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Living up to a name: the role of the VLDL receptor in lipid metabolism.
    Tacken PJ; Hofker MH; Havekes LM; van Dijk KW
    Curr Opin Lipidol; 2001 Jun; 12(3):275-9. PubMed ID: 11353330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Normal production rate of apolipoprotein B in LDL receptor-deficient mice.
    Millar JS; Maugeais C; Fuki IV; Rader DJ
    Arterioscler Thromb Vasc Biol; 2002 Jun; 22(6):989-94. PubMed ID: 12067909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mouse very low-density lipoprotein receptor (VLDLR): gene structure, tissue-specific expression and dietary and developmental regulation.
    Tiebel O; Oka K; Robinson K; Sullivan M; Martinez J; Nakamuta M; Ishimura-Oka K; Chan L
    Atherosclerosis; 1999 Aug; 145(2):239-51. PubMed ID: 10488949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The low density lipoprotein receptor prevents secretion of dense apoB100-containing lipoproteins from the liver.
    Larsson SL; Skogsberg J; Björkegren J
    J Biol Chem; 2004 Jan; 279(2):831-6. PubMed ID: 14583618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apolipoprotein E2 reduces the low density lipoprotein level in transgenic mice by impairing lipoprotein lipase-mediated lipolysis of triglyceride-rich lipoproteins.
    Huang Y; Liu XQ; Rall SC; Mahley RW
    J Biol Chem; 1998 Jul; 273(28):17483-90. PubMed ID: 9651338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cafestol increases serum cholesterol levels in apolipoprotein E*3-Leiden transgenic mice by suppression of bile acid synthesis.
    Post SM; de Roos B; Vermeulen M; Afman L; Jong MC; Dahlmans VE; Havekes LM; Stellaard F; Katan MB; Princen HM
    Arterioscler Thromb Vasc Biol; 2000 Jun; 20(6):1551-6. PubMed ID: 10845871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Very low-density lipoprotein receptor mediates triglyceride-rich lipoprotein-induced oxidative stress and insulin resistance.
    Hajri T; Gharib M; Fungwe T; M'Koma A
    Am J Physiol Heart Circ Physiol; 2024 Oct; 327(4):H733-H748. PubMed ID: 38787383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mouse very-low-density-lipoprotein receptor (VLDLR) cDNA cloning, tissue-specific expression and evolutionary relationship with the low-density-lipoprotein receptor.
    Oka K; Ishimura-Oka K; Chu MJ; Sullivan M; Krushkal J; Li WH; Chan L
    Eur J Biochem; 1994 Sep; 224(3):975-82. PubMed ID: 7925422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protection from obesity in mice lacking the VLDL receptor.
    Goudriaan JR; Tacken PJ; Dahlmans VE; Gijbels MJ; van Dijk KW; Havekes LM; Jong MC
    Arterioscler Thromb Vasc Biol; 2001 Sep; 21(9):1488-93. PubMed ID: 11557677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Upregulation of hepatic LDL transport by n-3 fatty acids in LDL receptor knockout mice.
    Vasandani C; Kafrouni AI; Caronna A; Bashmakov Y; Gotthardt M; Horton JD; Spady DK
    J Lipid Res; 2002 May; 43(5):772-84. PubMed ID: 11971949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stimulation of the in vivo production of very low density lipoproteins by apolipoprotein E is independent of the presence of the low density lipoprotein receptor.
    Teusink B; Mensenkamp AR; van der Boom H; Kuipers F; van Dijk KW; Havekes LM
    J Biol Chem; 2001 Nov; 276(44):40693-7. PubMed ID: 11546779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deficiency in apolipoprotein E has a protective effect on diet-induced nonalcoholic fatty liver disease in mice.
    Karavia EA; Papachristou DJ; Kotsikogianni I; Giopanou I; Kypreos KE
    FEBS J; 2011 Sep; 278(17):3119-29. PubMed ID: 21740524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In LDL receptor-deficient mice, catabolism of remnant lipoproteins requires a high level of apoE but is inhibited by excess apoE.
    van Dijk KW; van Vlijmen BJ; van't Hof HB; van der Zee A; Santamarina-Fojo S; van Berkel TJ; Havekes LM; Hofker MH
    J Lipid Res; 1999 Feb; 40(2):336-44. PubMed ID: 9925664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The VLDL receptor plays a major role in chylomicron metabolism by enhancing LPL-mediated triglyceride hydrolysis.
    Goudriaan JR; Espirito Santo SM; Voshol PJ; Teusink B; van Dijk KW; van Vlijmen BJ; Romijn JA; Havekes LM; Rensen PC
    J Lipid Res; 2004 Aug; 45(8):1475-81. PubMed ID: 15145981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aggressive very low-density lipoprotein (VLDL) and LDL lowering by gene transfer of the VLDL receptor combined with a low-fat diet regimen induces regression and reduces macrophage content in advanced atherosclerotic lesions in LDL receptor-deficient mice.
    MacDougall ED; Kramer F; Polinsky P; Barnhart S; Askari B; Johansson F; Varon R; Rosenfeld ME; Oka K; Chan L; Schwartz SM; Bornfeldt KE
    Am J Pathol; 2006 Jun; 168(6):2064-73. PubMed ID: 16723719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.